Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 7,600 shares at $40.00 ($300K) on 2014-11-24, disclosed to the SEC on 2014-11-26.
Open-market sale of $300k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.50 | 7,500 | $296K | 98.7% |
| 2 | $40.00 | 100 | $4K | 1.3% |
| Total | $39.51 avg | 7,600 | $300K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |